For immediate release 27 October 2014 CSL to acquire Novartis influenza vaccine business CSL Limited (ASX:CSL; USOTC:CSLLY) today announced that it has agreed to acquire Novartis’ global influenza vaccine business for - Global Vaccines - Document - PDFSEARCH.IO

First Page	Meta Content
	For immediate release 27 October 2014 CSL to acquire Novartis influenza vaccine business CSL Limited (ASX:CSL; USOTC:CSLLY) today announced that it has agreed to acquire Novartis’ global influenza vaccine business for Add to Reading List Document Date: 2014-10-26 17:33:41 Open Document File Size: 133,80 KB Share Result on Facebook Company Novartis / bioCSL / CSL Limited / / Country Germany / United States / Australia / United Kingdom / / Currency USD / / / Event M&A / Conference Call / / IndustryTerm media conference call / state-ofthe-art manufacturing facilities / pharmaceutical acquisitions / manufacturing plants / / MedicalCondition influenza / / Person Paul Perreault / Natalie de Vane Snr / / / Position Mark Dehring Head / Managing Director and Chief Executive Officer / Chief Executive Officer / Director Corporate Communications CSL Behring Phone / global player / analyst / Annual General / / SocialTag Health CSL Behring Influenza vaccine CSL Limited Influenza Novartis FluMist Pandemic Vaccination Vaccines

For immediate release 27 October 2014 CSL to acquire Novartis influenza vaccine business CSL Limited (ASX:CSL; USOTC:CSLLY) today announced that it has agreed to acquire Novartis’ global influenza vaccine business for Add to Reading List